The medicine helps improve symptoms of other problems too, like feeling nervous and weak in people with high thyroid hormone levels
Emerging therapies, including anti-IL-23 agents, TL1A inhibitors, and receptor-interacting protein kinase 1 (RIPK1) inhibitors, offer novel, targeted strategies to modulate inflammation, thereby expanding the therapeutic landscape and providing new options for patients with IBD
Importantly, individuals expressing greater body dissatisfaction and weight-related concerns appear most interested in pharmacologic treatment, and demand for these agents extends beyond those with medical indications
G.KellyL.HeY.WaliczekT.KordowerJ
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis
Relevant to laboratory investigations involving pineal peptide biology, CNS signaling, neuroprotective pathway models, and peptide-fragment response systems